About
Profound Medical Inc. is a commercial-stage medical technology company based in Mississauga, Ontario, Canada. The company specializes in developing and commercializing proprietary magnetic resonance (MR) guided focused ultrasound devices that provide incision-free ablative therapies for treating diseased tissue. Profound Medical is publicly traded on the TSX and NASDAQ. The company offers two main MRI-guided ultrasound ablation platforms: TULSA-PRO® and Sonalleve®. TULSA-PRO® is a catheter-based system designed for prostate cancer treatment, utilizing real-time temperature imaging and thermal ultrasound energy. Sonalleve® focuses on treating uterine fibroids with high-intensity focused ultrasound. Both platforms emphasize customizable and predictable ablation with real-time imaging guidance, enhancing safety and efficacy. Profound Medical's customers include hospitals and medical centers specializing in urology and gynecology, as well as clinicians and surgeons seeking advanced, minimally invasive treatment options. The company is committed to commercializing its products and expanding their adoption in various healthcare settings.
Technologies
Keywords
Company Information
-
Employees 150
-
Founded 2008
-
Annual Revenue $11369000
-
Total Funding $52064973
Location
2400 Skymark Ave, Mississauga, Ontario, Canada, L4W 5K5